|
⚲
|
| Keyboard |
| MPM SunStates Fund LP
✚
|
|
|---|---|
| CIK # | 0001765022 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001765022] | |
| 4 | [0001765022] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| MPM SunStates Fund LP | |
| MPM SunStates GP Managing Member LLC | |
| TCR2 Therapeutics Inc | |
| MPM Asset Management Investors SunStates Fund LLC | |
| MPM SunStates Fund GP LLC | |
| Oncorus Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2023-06-01 | Other | 4,158,964 | $0.00 | |
|
Oncorus Inc ONCR
Common Stock
|
2020-10-06 | Conversion | 1,783,879 | ||
|
Oncorus Inc ONCR
Common Stock
|
2020-10-06 | Buy | 173,776 | $15.00 | 2,606,640 |
|
Oncorus Inc ONCR
Common Stock
|
2020-10-06 | Conversion | 775,975 | ||
|
Oncorus Inc ONCR
Series A-1 Preferred Stock · derivative
|
2020-10-06 | Conversion | 1,783,879 | $0.00 | |
|
Oncorus Inc ONCR
Series B Preferred Stock · derivative
|
2020-10-06 | Conversion | 775,975 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2019-02-19 | Conversion | 2,825,396 | ||
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2019-02-19 | Buy | 706,666 | $15.00 | 10,599,990 |
|
TCR2 Therapeutics Inc TCRR
Series A Preferred Stock · derivative
|
2019-02-19 | Conversion | 17,500,000 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Series B Preferred Stock · derivative
|
2019-02-19 | Conversion | 2,000,000 | $0.00 | |
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2019-02-19 | Conversion | 322,901 |